Missing/wrong data?
Log in to edit
A Phase I-II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline BRCA1/2-Mutated Ovarian Carcinoma or Other Solid Tumors
scientific article published on 6 March 2017
Author/s
author: Judith Balmaña, Susan M Domchek, Ronnie Shapira-Frommer, Jeffrey Dean Isaacson, Amit M. Oza
Work details
Publication date
March 6, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.